CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Porters Five Forces analysis
3.3. Key findings

3.3.1. Top investment pockets, 2017
3.3.2. Top player positioning, 2017

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Growth in popularity of capsules over other drug delivery forms
3.4.1.2. Increase in strategic collaboration between empty capsule suppliers and gelatin manufacturers
3.4.1.3. Rise in advancements in the development of capsules

3.4.2. Restraints

3.4.2.1. Ethical concerns along with the price fluctuations regarding gelatin material
3.4.2.2. Stringent regulations in pharmaceutical industry

3.4.3. Opportunity

3.4.3.1. Developing economies offer lucrative opportunities

CHAPTER 4: EMPTY CAPSULES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Gelatin Capsules

4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Hard Gelatin Capsules (HGCs)

4.2.4.1. Market Size and Forecast

4.2.5. Soft Gelatin

4.2.5.1. Market Size and Forecast

4.3. Non-Gelatin

4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

CHAPTER 5: EMPTY CAPSULES MARKET, BY RAW MATERIAL

5.1. Overview.

5.1.1. Market size and forecast

5.2. Pig Meat

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Bovine Meat

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Bone

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. HPMC

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Other Raw Materials

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

CHAPTER 6: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION

6.1. Overview.

6.1.1. Market size and forecast

6.2. Antibiotic & Antibacterial Drugs

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Vitamin & Dietary Supplements

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Antacids & Anti-flatulent Preparations

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

6.5. Cardiac Therapy Drugs

6.5.1. Market size and forecast
6.5.2. Market analysis, by country

6.6. Other Applications

6.6.1. Market size and forecast
6.6.2. Market analysis, by country

CHAPTER 7: EMPTY CAPSULES MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Pharmaceuticals Manufacturers

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Nutraceutical Manufacturers

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. Other End Users

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

CHAPTER 8: EMPTY CAPSULES MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key trends and opportunities
8.2.2. North America market size and forecast, by country

8.2.2.1. U.S. market size and forecast, by product
8.2.2.2. U.S. market size and forecast, by raw material
8.2.2.3. U.S. market size and forecast, by therapeutic application
8.2.2.4. U.S. market size and forecast, by end user
8.2.2.5. Canada market size and forecast, by product
8.2.2.6. Canada market size and forecast, by raw material
8.2.2.7. Canada market size and forecast, by therapeutic application
8.2.2.8. Canada market size and forecast, by end user
8.2.2.9. Mexico market size and forecast, by product
8.2.2.10. Mexico market size and forecast, by raw material
8.2.2.11. Mexico market size and forecast, by therapeutic application
8.2.2.12. Mexico market size and forecast, by end user

8.2.3. North America market size and forecast, by product
8.2.4. North America market size and forecast, by raw material
8.2.5. North America market size and forecast, by therapeutic application
8.2.6. North America market size and forecast, by end user

8.3. Europe

8.3.1. Key trends and opportunities
8.3.2. Europe market size and forecast, by country

8.3.2.1. Germany market size and forecast, by product
8.3.2.2. Germany market size and forecast, by raw material
8.3.2.3. Germany market size and forecast, by therapeutic application
8.3.2.4. Germany market size and forecast, by end user
8.3.2.5. UK market size and forecast, by product
8.3.2.6. UK market size and forecast, by raw material
8.3.2.7. UK market size and forecast, by therapeutic application
8.3.2.8. UK market size and forecast, by end user
8.3.2.9. France market size and forecast, by product
8.3.2.10. France market size and forecast, by raw material
8.3.2.11. France market size and forecast, by therapeutic application
8.3.2.12. France market size and forecast, by end user
8.3.2.13. Rest of Europe market size and forecast, by product
8.3.2.14. Rest of Europe market size and forecast, by raw material
8.3.2.15. Rest of Europe market size and forecast, by therapeutic application
8.3.2.16. Rest of Europe market size and forecast, by end user

8.3.3. Europe market size and forecast, by product
8.3.4. Europe market size and forecast, by raw material
8.3.5. Europe market size and forecast, by therapeutic application
8.3.6. Europe market size and forecast, by end user

8.4. Asia-Pacific

8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size and forecast, by country

8.4.2.1. Japan market size and forecast, by product
8.4.2.2. Japan market size and forecast, by raw material
8.4.2.3. Japan market size and forecast, by therapeutic application
8.4.2.4. Japan market size and forecast, by end user
8.4.2.5. China market size and forecast, by product
8.4.2.6. China market size and forecast, by raw material
8.4.2.7. China market size and forecast, by therapeutic application
8.4.2.8. China market size and forecast, by end user
8.4.2.9. India market size and forecast, by product
8.4.2.10. India market size and forecast, by raw material
8.4.2.11. India market size and forecast, by therapeutic application
8.4.2.12. India market size and forecast, by end user
8.4.2.13. Rest of Asia-Pacific market size and forecast, by product
8.4.2.14. Rest of Asia-Pacific market size and forecast, by raw material
8.4.2.15. Rest of Asia-Pacific market size and forecast, by therapeutic application
8.4.2.16. Rest of Asia-Pacific market size and forecast, by end user

8.4.3. Asia-Pacific market size and forecast, by product
8.4.4. Asia-Pacific market size and forecast, by raw material
8.4.5. Asia-Pacific market size and forecast, by therapeutic application
8.4.6. Asia-Pacific market size and forecast, by end user

8.5. CIS

8.5.1. Key trends and opportunities
8.5.2. CIS market size and forecast, by country

8.5.2.1. Russia market size and forecast, by product
8.5.2.2. Russia market size and forecast, by raw material
8.5.2.3. Russia market size and forecast, by therapeutic application
8.5.2.4. Russia market size and forecast, by end user
8.5.2.5. Kazakhstan market size and forecast, by product
8.5.2.6. Kazakhstan market size and forecast, by raw material
8.5.2.7. Kazakhstan market size and forecast, by therapeutic application
8.5.2.8. Kazakhstan market size and forecast, by end user
8.5.2.9. Azerbaijan market size and forecast, by product
8.5.2.10. Azerbaijan market size and forecast, by raw material
8.5.2.11. Azerbaijan market size and forecast, by therapeutic application
8.5.2.12. Azerbaijan market size and forecast, by end user
8.5.2.13. Rest of CIS market size and forecast, by product
8.5.2.14. Rest of CIS market size and forecast, by raw material
8.5.2.15. Rest of CIS market size and forecast, by therapeutic application
8.5.2.16. Rest of CIS market size and forecast, by end user

8.5.3. CIS market size and forecast, by product
8.5.4. CIS market size and forecast, by raw material
8.5.5. CIS market size and forecast, by therapeutic application
8.5.6. CIS market size and forecast, by end user

8.6. MENA

8.6.1. Key trends and opportunities
8.6.2. MENA market size and forecast, by country

8.6.2.1. Saudi Arabia market size and forecast, by product
8.6.2.2. Saudi Arabia market size and forecast, by raw material
8.6.2.3. Saudi Arabia market size and forecast, by therapeutic application
8.6.2.4. Saudi Arabia market size and forecast, by end user
8.6.2.5. Iran market size and forecast, by product
8.6.2.6. Iran market size and forecast, by raw material
8.6.2.7. Iran market size and forecast, by therapeutic application
8.6.2.8. Iran market size and forecast, by end user
8.6.2.9. UAE market size and forecast, by product
8.6.2.10. UAE market size and forecast, by raw material
8.6.2.11. UAE market size and forecast, by therapeutic application
8.6.2.12. UAE market size and forecast, by end user
8.6.2.13. Algeria market size and forecast, by product
8.6.2.14. Algeria market size and forecast, by raw material
8.6.2.15. Algeria market size and forecast, by therapeutic application
8.6.2.16. Algeria market size and forecast, by end user
8.6.2.17. Egypt market size and forecast, by product
8.6.2.18. Egypt market size and forecast, by raw material
8.6.2.19. Egypt market size and forecast, by therapeutic application
8.6.2.20. Egypt market size and forecast, by end user
8.6.2.21. Rest of MENA market size and forecast, by product
8.6.2.22. Rest of MENA market size and forecast, by raw material
8.6.2.23. Rest of MENA market size and forecast, by therapeutic application
8.6.2.24. Rest of MENA market size and forecast, by end user

8.6.3. MENA market size and forecast, by product
8.6.4. MENA market size and forecast, by raw material
8.6.5. MENA market size and forecast, by therapeutic application
8.6.6. MENA market size and forecast, by end user

CHAPTER 9: COMPANY PROFILES

9.1. ACG Worldwide

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio

9.2. Bright Pharma Caps Inc.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Product portfolio
9.2.4. Key strategic moves and developments

9.3. CapsCanada Corporation

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product portfolio
9.3.4. Key strategic moves and developments

9.4. Lonza Group Ltd. (Capsugel)

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments

9.5. Medi-Caps Ltd.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance

9.6. Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments

9.7. Roxlor LLC

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio

9.8. Snail Pharma Industry Co. Ltd.

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio

9.9. Suheung Co., Ltd.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Product portfolio

9.10. Sunil Healthcare Ltd.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments